Key Points
- Insider sale: Quantum-Si insider John Vieceli sold 15,112 shares on June 23 at an average price of $0.90, worth about $13,600.80. After the transaction, he still held 1,140,434 shares.
- Stock and financial snapshot: QSI opened at $0.83 and has traded between $0.69 and $3.10 over the past 12 months. The company recently beat EPS estimates but missed revenue expectations and remains unprofitable.
- Wall Street view: Analysts are cautious on Quantum-Si, with an average rating of “Reduce” and a price target of $1.00. Institutional ownership stands at about 39.9% of the company.
Quantum-Si Incorporated (NASDAQ:QSI - Get Free Report) CEO Jeffrey Alan Hawkins sold 11,311 shares of the stock in a transaction on Tuesday, June 23rd. The shares were sold at an average price of $0.90, for a total value of $10,179.90. Following the completion of the sale, the chief executive officer owned 3,669,802 shares of the company's stock, valued at approximately $3,302,821.80. This represents a 0.31% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
Jeffrey Alan Hawkins also recently made the following trade(s):
- On Monday, June 22nd, Jeffrey Alan Hawkins sold 11,310 shares of Quantum-Si stock. The stock was sold at an average price of $0.96, for a total value of $10,857.60.
- On Monday, April 20th, Jeffrey Alan Hawkins sold 83,712 shares of Quantum-Si stock. The stock was sold at an average price of $1.01, for a total value of $84,549.12.
Quantum-Si Stock Performance
QSI stock opened at $0.83 on Thursday. Quantum-Si Incorporated has a 1 year low of $0.69 and a 1 year high of $3.10. The firm has a market cap of $180.13 million, a P/E ratio of -1.62 and a beta of 3.18. The stock has a 50-day simple moving average of $0.99 and a 200-day simple moving average of $1.04.
Quantum-Si (NASDAQ:QSI - Get Free Report) last announced its earnings results on Thursday, May 7th. The company reported ($0.10) EPS for the quarter, beating the consensus estimate of ($0.12) by $0.02. The business had revenue of $0.26 million for the quarter, compared to the consensus estimate of $0.30 million. Quantum-Si had a negative return on equity of 47.35% and a negative net margin of 5,605.88%. On average, equities research analysts predict that Quantum-Si Incorporated will post -0.49 EPS for the current year.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of the business. Prudential Financial Inc. acquired a new position in shares of Quantum-Si in the second quarter worth about $25,000. Curbstone Financial Management Corp acquired a new stake in Quantum-Si during the 4th quarter valued at approximately $26,000. Leonteq Securities AG acquired a new stake in Quantum-Si during the 4th quarter valued at approximately $28,000. Cerity Partners LLC purchased a new stake in Quantum-Si during the 2nd quarter worth approximately $29,000. Finally, Hollencrest Capital Management increased its holdings in Quantum-Si by 301.1% during the 1st quarter. Hollencrest Capital Management now owns 40,111 shares of the company's stock worth $31,000 after purchasing an additional 30,111 shares during the last quarter. Institutional investors and hedge funds own 39.90% of the company's stock.
Analysts Set New Price Targets
A number of research firms have recently issued reports on QSI. Weiss Ratings reiterated a "sell (d-)" rating on shares of Quantum-Si in a research note on Friday, March 27th. Canaccord Genuity Group lowered their price target on shares of Quantum-Si from $1.50 to $1.00 and set a "hold" rating for the company in a report on Wednesday, March 4th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Reduce" and an average target price of $1.00.
Read Our Latest Research Report on QSI
Quantum-Si Company Profile
(
Get Free Report)
Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.
Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
